CEMIPLIMAB-RWLC for Cervix carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 43 adverse event reports in the FDA FAERS database where CEMIPLIMAB-RWLC was used for Cervix carcinoma.
Most Reported Side Effects for CEMIPLIMAB-RWLC
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 128 | 8.2% | 126 | 13 |
| Disease progression | 101 | 6.5% | 29 | 15 |
| Fatigue | 71 | 4.6% | 10 | 19 |
| Off label use | 68 | 4.4% | 12 | 12 |
| Rash | 64 | 4.1% | 2 | 17 |
| Dyspnoea | 55 | 3.5% | 12 | 25 |
| Pyrexia | 52 | 3.4% | 8 | 41 |
| Pruritus | 44 | 2.8% | 1 | 10 |
| Asthenia | 42 | 2.7% | 16 | 23 |
| Diarrhoea | 42 | 2.7% | 5 | 27 |
| Myocarditis | 42 | 2.7% | 19 | 27 |
| Interstitial lung disease | 39 | 2.5% | 3 | 24 |
| Nausea | 38 | 2.5% | 12 | 26 |
| Drug ineffective | 34 | 2.2% | 3 | 2 |
| Pneumonitis | 33 | 2.1% | 3 | 18 |
Other Indications for CEMIPLIMAB-RWLC
Squamous cell carcinoma of skin (370)
Product used for unknown indication (348)
Squamous cell carcinoma (234)
Non-small cell lung cancer (83)
Cervix carcinoma recurrent (72)
Basal cell carcinoma (42)
Metastatic squamous cell carcinoma (42)
Lung neoplasm malignant (34)
Neoplasm malignant (33)
Lung adenocarcinoma (32)
Other Drugs Used for Cervix carcinoma
PACLITAXEL (1,061)
BEVACIZUMAB (1,017)
PEMBROLIZUMAB (791)
CARBOPLATIN (755)
CISPLATIN (685)
TISOTUMAB VEDOTIN-TFTV (163)
ATEZOLIZUMAB (157)
NIVOLUMAB (124)
GEMCITABINE (73)
IPILIMUMAB (66)